Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
ResMed Inc. has disclosed a planned sale of 4,991 common shares by Chief Executive Officer and Director Michael J. Farrell under a Rule 144 filing, with the transaction to be executed through Fidelity Brokerage Services on the New York Stock Exchange. The shares, acquired via stock options granted in 2019 and exercised in April 2026, follow a series of similar-sized monthly sales in the first quarter, signaling ongoing executive share disposals that investors may monitor for insights into insider sentiment and personal diversification rather than any undisclosed operational issues.
The filing notes that Farrell’s trading activity is conducted under a pre-established Rule 10b5-1 plan adopted in October 2024, designed to structure sales independently of day-to-day market conditions or new internal information. The representation within the notice affirms that the seller is not aware of any material adverse, non-public information about ResMed’s current or future operations, providing some reassurance to shareholders that these insider transactions are routine and compliant with U.S. securities regulations.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. is a medical technology company specializing in devices and software for the diagnosis, treatment, and management of sleep-disordered breathing and other chronic respiratory conditions. The company focuses on global markets for sleep apnea therapy and respiratory care, supplying equipment such as CPAP devices, ventilators, and related digital health solutions.
Average Trading Volume: 1,208,613
Technical Sentiment Signal: Hold
Current Market Cap: A$47.48B
Learn more about RMD stock on TipRanks’ Stock Analysis page.